Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
55.45
-2.11 (-3.67%)
At close: Apr 9, 2026

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
25,76426,56417,23719,53016,03014,959
Market Cap Growth
35.31%54.11%-11.74%21.83%7.16%-
Enterprise Value
25,07025,70417,34218,89114,51814,805
Last Close Price
55.4557.6041.4747.8539.3737.01
PS Ratio
32.1633.1647.89213.94-1454.37
PB Ratio
19.8820.5086.1623.019.126.07
P/TBV Ratio
28.7129.60-50.5112.667.53
EV/Sales Ratio
31.2932.0848.18206.94-1439.37
Debt / Equity Ratio
0.960.965.790.480.050.04
Net Debt / Equity Ratio
-0.54-0.541.59-0.40-0.76-0.81
Net Debt / EBITDA Ratio
0.970.97-0.340.301.773.12
Net Debt / FCF Ratio
0.920.92-0.400.341.973.97
Asset Turnover
0.340.340.220.05-0.01
Inventory Turnover
0.840.840.350.54--
Quick Ratio
2.112.111.111.785.709.82
Current Ratio
2.222.221.272.035.939.96
Return on Equity (ROE)
-102.76%-102.76%-179.21%-84.98%-34.87%-37.83%
Return on Assets (ROA)
-20.13%-20.13%-37.70%-40.35%-20.52%-21.46%
Return on Capital Employed (ROCE)
-37.70%-37.70%-103.90%-110.20%-43.20%-26.60%
Earnings Yield
-2.97%-2.88%-4.91%-5.67%-4.59%-4.48%
FCF Yield
-2.95%-2.86%-4.57%-5.12%-4.22%-3.35%
Buyback Yield / Dilution
-7.75%-7.75%-1.83%-0.70%-12.29%-0.07%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.